| NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 70748-0208-07 | 70748-0208 | Dasatinib | Dasatinib | 20.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | BCR-ABL | Oral | Jan 30, 2026 | In Use | |
| 71921-0150-25 | 71921-0150 | Mercaptopurine | Mercaptopurine | 50.0 mg/1 | Chemotherapy | Antimetabolite | Purine Analog | Oral | Jan 30, 2026 | In Use | |
| 70748-0210-07 | 70748-0210 | Dasatinib | Dasatinib | 70.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | BCR-ABL | Oral | Jan 30, 2026 | In Use | |
| 70748-0213-06 | 70748-0213 | Dasatinib | Dasatinib | 140.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | BCR-ABL | Oral | Jan 30, 2026 | In Use | |
| 71921-0150-02 | 71921-0150 | Mercaptopurine | Mercaptopurine | 50.0 mg/1 | Chemotherapy | Antimetabolite | Purine Analog | Oral | Jan 30, 2026 | In Use | |
| 70748-0212-06 | 70748-0212 | Dasatinib | Dasatinib | 100.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | BCR-ABL | Oral | Jan 30, 2026 | In Use | |
| 70748-0211-06 | 70748-0211 | Dasatinib | Dasatinib | 80.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | BCR-ABL | Oral | Jan 30, 2026 | In Use | |
| 70748-0209-07 | 70748-0209 | Dasatinib | Dasatinib | 50.0 mg/1 | Chemotherapy | Tyrosine Kinase Inhibitor | BCR-ABL | Oral | Jan 30, 2026 | In Use | |
| 68001-0667-19 | 68001-0667 | Aprepitant | Aprepitant | 80.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Jan 29, 2026 | In Use | |
| 68001-0666-01 | 68001-0666 | Aprepitant | Aprepitant | 40.0 mg/1 | Ancillary Therapy | Antiemetic | Substance P/Neurokinin 1 | Oral | Jan 29, 2026 | In Use | |
| 67457-0762-30 | 67457-0762 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | 5.0 mg/mL | Hormonal Therapy | Somatostatin Analog | Jan 28, 2026 | In Use | |||
| 76420-0414-21 | 76420-0414 | PREDNISONE | Prednisone | 50.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan 28, 2026 | In Use | |
| 67457-0759-20 | 67457-0759 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | 3.33 mg/mL | Hormonal Therapy | Somatostatin Analog | Intramuscular | Jan 28, 2026 | In Use | ||
| 76420-0413-21 | 76420-0413 | PREDNISONE | Prednisone | 20.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan 28, 2026 | In Use | |
| 76420-0412-21 | 76420-0412 | PREDNISONE | Prednisone | 10.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan 28, 2026 | In Use | |
| 67457-0756-10 | 67457-0756 | OCTREOTIDE ACETATE | OCTREOTIDE ACETATE | 1.667 mg/mL | Hormonal Therapy | Somatostatin Analog | Intramuscular | Jan 28, 2026 | In Use | ||
| 55150-0520-01 | 55150-0520 | MESNA | MESNA | 100.0 mg/mL | Ancillary Therapy | Chemoprotective | Detoxifying Agent | Intravenous | Jan 27, 2026 | In Use | |
| 68071-3958-09 | 68071-3958 | PREDNISONE | PREDNISONE | 1.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan 26, 2026 | In Use | |
| 76420-0414-10 | 76420-0414 | PREDNISONE | Prednisone | 50.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan 24, 2026 | In Use | |
| 76420-0413-10 | 76420-0413 | PREDNISONE | Prednisone | 20.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan 24, 2026 | In Use | |
| 76420-0412-10 | 76420-0412 | PREDNISONE | Prednisone | 10.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan 24, 2026 | In Use | |
| 68071-2509-09 | 68071-2509 | PredniSONE | PredniSONE | 5.0 mg/1 | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan 23, 2026 | In Use | |
| 43598-0125-11 | 43598-0125 | Eribulin Mesylate | Eribulin Mesylate | 0.5 mg/mL | Chemotherapy | Antimitotic Agent | Furopyrans | Intravenous | Jan 22, 2026 | In Use | |
| 85766-0134-05 | 85766-0134 | Triamcinolone Acetonide | Triamcinolone Acetonide | 200.0 mg/5mL | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Intra-articular, Intramuscular | Jan 20, 2026 | In Use | |
| 87063-0077-05 | 87063-0077 | Triamcinolone Acetonide | Triamcinolone Acetonide | 200.0 mg/5mL | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Intra-articular, Intramuscular | Jan 20, 2026 | In Use |
Found 12393 results — Export these results
Home